Clinical trial
Mass Cytometry-based Peripheral Blood Immune Model for Accurate Detection of Cervical Lesions in HPV16/18-positive Women: a Multicenter Study
NCT07606677 is registered in ClinicalTrials.gov with Women's Hospital School Of Medicine Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mass Cytometry-based Peripheral Blood Immune Model for Accurate Detection of Cervical Lesions in HPV16/18-positive Women: a Multicenter Study
- Lead sponsor
- Women's Hospital School Of Medicine Zhejiang University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 15, 2026
- Completion date
- March 31, 2028
- Enrollment
- 1,465 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
cervical cancer (early detection), cin 2/3